NewslettersImmune Regulation NewsSUSD2 Suppresses CD8+ T Cell Antitumor Immunity by Targeting IL-2 Receptor SignalingBy Bob - October 21, 20220302Susd2−/− effector CD8+ T cells showed enhanced production of antitumor molecules, which consequently blunted tumor growth in multiple syngeneic mouse tumor models.[Nature Immunology]Abstract